OREGON S LESS IAN/GAY/B l/T RAN S/QU E E R NEWSMAGAZINE
OCTOBER 15 2010 | 9
I am outgoing.
I am on th e go.
I am a n e w ly w e d .
I am H IV positive.
You are special, unique, and different from anyone else.
A nd so is yo u r path to m anaging HIV. W hen y o u ’re ready
to sta rt HIV therapy, talk to yo u r d o c to r a b ou t a m edication
th a t m ay fit yo u r needs and lifestyle.
In clinical studies lasting 96 weeks, patients being treated with HIV medication for the
first time who took ISENTRESS plus Truvada:
♦ Had a low rate of side effects
— The most common side effect of moderate to severe intensity (that interfered
with or kept patients from performing daily activities) was trouble sleeping
— This side effect occurred more often in patients taking ISENTRESS plus Truvada
(4%) versus Sustiva plus Truvada (3%)
♦ Experienced less effect on LDL cholesterol (“bad” cholesterol)
— Cholesterol increased an average of 7 mg/dL with ISENTRESS plus Truvada
versus 21 mg/dL with Sustiva plus Truvada
A sk yo u r d o c to r a b o u t ISENTRESS.
N o t s u re w h e re to s ta rt? Visit is e n tre s s .c o m /q u e s tio n s
People taking ISENTRESS may still develop infections, including opportunistic infections or other conditions that
occur with HIV infection.
Tell your doctor about all of your medical conditions, including if you have any allergies, are pregnant or plan to
become pregnant, or are breast-feeding or plan to breast-feed. ISENTRESS is not recommended for use during
pregnancy. Women with HIV should not breast-feed because their babies could be infected with HIV through their
breast milk.
Tell your doctor about all the medicines you take, including prescription medicines like rifampin (a medicine used
to treat infections such as tuberculosis), non-prescription medicines, vitamins, and herbal supplements.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
For more information about ISENTRESS, please read the Patient Information on the following page.
Need help paying for ISENTRESS?
Call 1-866-350-9232
ISENTRESS is a registered trademark o l Merck Sharp & Dohme Corp.. a subsidiary of Merck & Co., Inc.
Copyright © 2010 Merck Sharp & Dohme C orp. a subsidiary of
21052250(25)010) 10/10-ISN CON
Sustiva is a registered trademark of Bristol-Myers Squibb
Truvada is a registered trademark of Gilead Sciences. Inc.
Merck & Co., Inc.
All rights reserved.
ISENTRESS
raltegravir tablets